Psychiatry Research: Neuroimaging
Volume 164, Issue 2 , Pages 123-131 , 30 November 2008

Gray matter structural alterations in obsessive–compulsive disorder: Relationship to neuropsychological functions

  • Christopher J. Christian

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • ,
  • Todd Lencz

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States
    • ,
  • Delbert G. Robinson

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States
    • ,
  • Katherine E. Burdick

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States
    • ,
  • Manzar Ashtari

      Affiliations

    • Department of Radiology, The Children’s Hospital of Philadelphia, Philadelphia, PA, United States
    • ,
  • Anil K. Malhotra

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States
    • ,
  • Julia D. Betensky

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • ,
  • Philip R. Szeszko

      Affiliations

    • Zucker Hillside Hospital, Psychiatry Research, Glen Oaks, NY, United States
    • Albert Einstein College of Medicine, Bronx, NY, United States
    • Feinstein Institute for Medical Research, Manhasset, NY, United States
    • Corresponding Author InformationCorresponding author. Zucker Hillside Hospital, Psychiatry Research, 75-59 263rd Street, Glen Oaks, NY 11004, United States. Tel.: +1 718 470 8489; fax: +1 718 343 1659.

Received 5 March 2007 ,Revised 8 February 2008 ,Accepted 8 March 2008.

References 

  1. Abbruzzese M, Bellodi L, Ferri S, Scarone S. Frontal lobe dysfunction in schizophrenia and obsessive–compulsive disorder: a neuropsychological study. Brain and Cognition. 1995;27:202–212
  2. Abbruzzese M, Ferri S, Scarone S. Wisconsin Card Sorting Test performance in obsessive–compulsive disorder: no evidence for involvement of dorsolateral prefrontal cortex. Psychiatry Research. 1995;58:37–43
  3. Abbruzzese M, Ferri S, Scarone S. The selective breakdown of frontal functions in patients with obsessive–compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia. 1997;35:907–912
  4. Adler CM, McDonough-Ryan P, Sax KW, Holland SK, Arndt S, Strakowski SM. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. Journal of Psychiatric Research. 2000;34:317–324
  5. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience. 1986;9:357–381
  6. Alptekin K, Degirmenci B, Kivircik B, Durak H, Yemez B, Derebek E, et al. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive–compulsive patients without depression. Psychiatry Research. 2001;107:51–56
  7. Atmaca M, Yildirim H, Ozdemir H, Tezcan E, Kursad Poyraz A. Volumetric MRI study of key brain regions implicated in obsessive–compulsive disorder. Progress in Neuropsychopharmacology & Biological Psychiatry. 2007;31:46–52
  8. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM. Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Research. 2002;110:165–174
  9. Bilder RM, Goldman RS, Robinson D, Reiter G, Bell L, Bates JA, et al. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. American Journal of Psychiatry. 2000;157:549–559
  10. Bolton D, Gibb W, Lees A, Raven P, Gray JA, Chen E, et al. Neurological soft signs in obsessive compulsive disorder: standardized assessment and comparison with schizophrenia. Behavioural Neurology. 1998;11:197–204
  11. Burdick, K.E., Robinson, D.G., Malhotra, A.K., Szeszko, P.R., in press. Neurocognitive profile analysis in obsessive-compulsive disorder. Journal of the International Neuropsychological Society.
  12. Bystritsky A, Liberman RP, Hwang S, Wallace CJ, Vapnik T, Maindment K, et al. Social functioning and quality of life comparisons between obsessive–compulsive and schizophrenic disorders. Depression and Anxiety. 2001;14:214–218
  13. Cavedini P, Ferri S, Scarone S, Bellodi L. Frontal lobe dysfunction in obsessive–compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Research. 1998;78:21–28
  14. Cavedini P, Riboldi G, D'Annucci A, Belotti P, Cisima M, Bellodi L. Decision-making heterogeneity in obsessive–compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia. 2002;40:205–211
  15. Cavedini P, Gorini A, Bellodi L. Understanding obsessive–compulsive disorder: focus on decision making. Neuropsychology Review. 2006;16:3–15
  16. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neuroscience and Biobehavioral Reviews. 2005;29:399–419
  17. Chamberlain SR, Fineberg NA, Blackwell AD, Clark L, Robbins TW, Sahakian BJ. A neuropsychological comparison of obsessive–compulsive disorder and trichotillomania. Neuropsychologia. 2007;45:654–662
  18. Chan RC, Rao H, Chen EE, Ye B, Zhang C. The neural basis of motor sequencing: an fMRI study of healthy subjects. Neuroscience Letters. 2006;398:189–194
  19. Chen XL, Xie JX, Han HB, Cui YH, Zhang BQ. MR perfusion-weighted imaging and quantitative analysis of cerebral hemodynamics with symptom provocation in unmedicated patients with obsessive–compulsive disorder. Neuroscience Letters. 2004;370:206–211
  20. Cummings JL. Anatomic and behavioral aspects of frontal–subcortical circuits. Annals of the New York Academy of Sciences. 1995;769:1–13
  21. Dhamala M, Pagnoni G, Wiesenfeld K, Zink CF, Martin M, Berns GS. Neural correlates of the complexity of rhythmic finger tapping. Neuroimage. 2003;20:918–926
  22. Elliott R, Dolan RJ, Frith CD. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cerebral Cortex. 2000;10:308–317
  23. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition (CID-I/P). New York: New York State Psychiatric Institute, Biometrics Research Department; 1994;
  24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM IV-TR Axis I Disorders — Non-patient Edition (SCID-I/NP). New York: New York State Psychiatric Institute, Biometrics Research Department; 2001;
  25. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, MacMaster FP, et al. Decrease in thalamic volumes of pediatric patients with obsessive–compulsive disorder who are taking paroxetine. Archives of General Psychiatry. 2000;57:449–456
  26. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14:21–36
  27. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry. 1989;46:1006–1011
  28. Grachev ID, Breiter HC, Rauch SL, Savage CR, Baer L, Shera DM, et al. Structural abnormalities of frontal neocortex in obsessive–compulsive disorder. Archives of General Psychiatry. 1998;55:181–182
  29. Hillary FG, Genova HM, Chiaravalloti ND, Rypma B, DeLuca J. Prefrontal modulation of working memory performance in brain injury and disease. Human Brain Mapping. 2006;27:837–847
  30. Hollander E, Schiffman E, Cohen B, Rivera-Stein MA, Rosen W, Gorman JM, et al. Signs of central nervous system dysfunction in obsessive–compulsive disorder. Archives General Psychiatry. 1990;47:27–32
  31. Kang DH, Kim JJ, Choi JS, Kim YI, Kim CW, Youn T, et al. Volumetric investigation of the frontal–subcortical circuitry in patients with obsessive–compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences. 2004;16:342–349
  32. Kim JJ, Lee MC, Kim J, Kim IY, Kim SI, Han MH, et al. Gray matter abnormalities in obsessive–compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. British Journal of Psychiatry. 2001;179:330–334
  33. Kim KW, Lee DY. Obsessive–compulsive disorder associated with a left orbitofrontal infarct. Journal of Neuropsychiatry and Clinical Neurosciences. 2002;14:88–89
  34. Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive–compulsive disorder: a critical review. Biological Psychology. 2004;65:185–236
  35. Lacerda AL, Dalgalarrondo P, Caetano D, Camargo EE, Etchebehere EC, Soares JC. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive–compulsive disorder: a SPECT study. Psychiatry Research. 2003;123:125–134
  36. Lehericy S, Bardinet E, Tremblay L, Van de Moortele PF, Pochon JB, Dormont D, et al. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cerebral Cortex. 2006;16:149–161
  37. Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biological Psychiatry. 2006;59:863–871
  38. Mataix-Cols D, Rauch SL, Manzo PA, Jenike MA, Baer L. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive–compulsive disorder. American Journal of Psychiatry. 1999;156:1409–1416
  39. Moll J, de Oliveira-Souza R, Moll FT, Bramati IE, Andreiuolo PA. The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arquivos de neuro-psiquiatria. 2002;60:900–905
  40. Okasha A, Rafaat M, Mahallawy N, El Nahas G, El Dawla AS, Sayed M, et al. Cognitive dysfunction in obsessive–compulsive disorder. Acta Psychiatrica Scandinavica. 2000;101:281–285
  41. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9:97–113
  42. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [18F]FDG PET study in obsessive–compulsive disorder. A clinical/metabolic correlation study after treatment. British Journal of Psychiatry. 1995;166:244–250
  43. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, et al. Mapping structural brain alterations in obsessive–compulsive disorder. Archives of General Psychiatry. 2004;61:720–730
  44. Purcell R, Maruff P, Kyrios M, Pantelis C. Neuropsychological deficits in obsessive–compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Archives of General Psychiatry. 1998;55:415–423
  45. Rachman S. Primary obsessional slowness. Behaviour Research and Therapy. 1974;12:9–18
  46. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, et al. Regional cerebral blood flow measured during symptom provocation in obsessive–compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives of General Psychiatry. 1994;51:62–70
  47. Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 2002;27:782–791
  48. Remijnse PL, Nielen MM, van Balkom AJ, Cath DC, van Oppen P, Uylings HB, et al. Reduced orbitofrontal–striatal activity on a reversal learning task in obsessive–compulsive disorder. Archives of General Psychiatry. 2006;63:1225–1236
  49. Rhinewine JP, Lencz T, Thaden EP, Cervellione KL, Burdick KE, Henderson I, et al. Neurocognitive profile in adolescents with early-onset schizophrenia: clinical correlates. Biological Psychiatry. 2005;58:705–712
  50. Rosenberg DR, Keshavan MS. Toward a neurodevelopmental model of obsessive–compulsive disorder. Biological Psychiatry. 1998;43:623–640
  51. Rosenberg DR, Dick EL, O'Hearn KM, Sweeney JA. Response-inhibition deficits in obsessive–compulsive disorder: an indicator of dysfunction in frontostriatal circuits. Journal of Psychiatry & Neuroscience. 1997;22:29–38
  52. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, et al. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive–compulsive disorder. Journal of Child and Adolescent Psychopharmacology. 2003;13:S31–S38
  53. Sawle GV, Hymas NF, Lees AJ, Frackowiak RS. Obsessional slowness. Functional studies with positron emission tomography. Brain. 1991;114:2191–2202
  54. Saxena S, Brody AL, Ho ML, Alborzian S, Ho MK, Maidment KM, et al. Cerebral metabolism in major depression and obsessive–compulsive disorder occurring separately and concurrently. Biological Psychiatry. 2001;50:159–170
  55. Saxena S, Brody AL, Ho ML, Alborzian S, Maidment KM, Zohrabi N, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive–compulsive disorder vs major depression. Archives of General Psychiatry. 2002;59:250–261
  56. Sim K, Cullen T, Ongur D, Heckers S. Testing models of thalamic dysfunction in schizophrenia using neuroimaging. Journal of Neural Transmission. 2006;113:907–928
  57. Stuss DT, Bisschop SM, Alexander MP, Levine B, Katz D, Izukawa D. The Trail Making Test: a study in focal lesion patients. Psychological Assessment. 2001;13:230–239
  58. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, et al. Cerebral glucose metabolism in childhood-onset obsessive–compulsive disorder. Revisualization during pharmacotherapy. Archives of General Psychiatry. 1992;49:690–694
  59. Sweet LH, Paskavitz JF, O'Connor MJ, Browndyke JN, Wellen JW, Cohen RA. FMRI correlates of the WAIS-III symbol search subtest. Journal of the International Neuropsychological Society. 2005;11:471–476
  60. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, et al. Orbital frontal and amygdala volume reductions in obsessive–compulsive disorder. Archives of General Psychiatry. 1999;56:913–919
  61. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive–compulsive disorder. American Journal of Psychiatry. 2004;161:1049–1056
  62. Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, et al. Amygdala volume reductions in pediatric patients with obsessive–compulsive disorder treated with paroxetine: preliminary findings. Neuropsychopharmacology. 2004;29:826–832
  63. Tata PR, Leibowitz JA, Prunty MJ, Cameron M, Pickering AD. Attentional bias in obsessional compulsive disorder. Acta Psychiatrica Scandinavica. 1996;101:281–285
  64. Valente AA, Miguel EC, Castro CC, Amaro E, Duran FL, Buchpiguel CA, et al. Regional gray matter abnormalities in obsessive–compulsive disorder: a voxel-based morphometry study. Biological Psychiatry. 2005;58:479–487
  65. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, et al. Frontal–striatal dysfunction during planning in obsessive–compulsive disorder. Archives of General Psychiatry. 2005;62:301–309

PII: S0925-4927(08)00050-4

doi: 10.1016/j.pscychresns.2008.03.005

Psychiatry Research: Neuroimaging
Volume 164, Issue 2 , Pages 123-131 , 30 November 2008

Article Tools

* Image Usage & Resolution